Norbel Inversiones, S.L.

Norbel Inversiones, S.L. appears in our data through filings on Laboratorios Farmaceuticos Rovi, S.A. shares, published by CNMV. We count 5 filings; the first trade dates from 22 June 2021 and the latest from 24 June 2022.

The open-market side counts 1 purchase for €2.2M alongside 4 sales for €339.4M. The net balance comes to €337.2M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2022 alone, the filings show no purchases and 3 sales.

The record was last updated on 29 June 2022 with an open-market sale (€32.8M) in Laboratorios Farmaceuticos Rovi, S.A. The last purchase on record was published on 29 July 2021, which is 1,913 days ago. Between a trade and the moment it shows up on CNMV, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by CNMV. They describe what insiders did and are not a recommendation.